Bookbuilding IPO | ₹1,024 Cr | Listed at BSE, NSE | Mon, Nov 15, 2021 - Wed, Nov 17, 2021
Tarsons Products IPO is a book build issue of ₹1,023.54 crores. The issue is a combination of fresh issue of 0.23 crore shares aggregating to ₹149.96 crores and offer for sale of 1.32 crore shares aggregating to ₹873.58 crores.
Tarsons Products IPO bidding started from Nov 15, 2021 and ended on Nov 17, 2021. The allotment for Tarsons Products IPO was finalized on Nov 23, 2021. The shares got listed on BSE, NSE on Nov 26, 2021.
Tarsons Products IPO price band is set at ₹662 per share. The lot size for an application is 22. The minimum amount of investment required by an retail is ₹14,564 (22 shares) (based on upper price). The lot size investment for sNII is 14 lots (308 shares), amounting to ₹2,03,896, and for bNII, it is 69 lots (1,518 shares), amounting to ₹10,04,916.
The issue includes a reservation of up to 60,000 shares for employees offered at a discount of ₹61.00 to the issue price.
Edelweiss Financial Services Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Tarsons Products IPO RHP for detailed Information.
IPO Open
Mon, Nov 15, 2021
IPO Close
Wed, Nov 17, 2021
Issue Price
₹662 per share
Market Cap (Pre-IPO)
₹3,522.26 Cr
| IPO Date | 15 to 17 Nov, 2021 |
| Listed on | Fri, Nov 26, 2021 |
| Face Value | ₹2 per share |
| Price Band | ₹635 to ₹662 |
| Issue Price | ₹662 per share |
| Lot Size | 22 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Employee Discount | ₹61.00 |
| Total Issue Size | 1,54,65,861 shares (agg. up to ₹1,024 Cr) |
| Fresh Issue | 22,65,862 shares (agg. up to ₹150 Cr) |
| Offer for Sale | 1,31,99,999 shares of ₹2 (agg. up to ₹874 Cr) |
| Share Holding Pre Issue | 5,09,40,420 shares |
| Share Holding Post Issue | 5,32,06,281 shares |
| BSE Script Code / NSE Symbol | 543399 / TARSONS |
| ISIN | INE144Z01023 |
Tarsons Products IPO comprises a total issue size of 1,54,65,861 shares. The net offer to the public is 1,54,05,861 shares, after excluding 60,000 shares under a preferential allotment. Of the Net offer 77,02,929 (50.00%) are allocated to QIB, 23,10,880 (15.00%) allocated to NII 53,92,052 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue | Max Allottees |
|---|---|---|---|---|
| QIB Shares Offered | 77,02,929 | 50.00% | 49.81% | NA |
| − Anchor Investor Shares Offered | 46,21,757 | 29.88% | NA | |
| − QIB (Ex. Anchor) Shares Offered | 30,81,172 | 19.92% | NA | |
| NII (HNI) Shares Offered | 23,10,880 | 15.00% | 14.94% | NA |
| Retail Shares Offered | 53,92,052 | 35.00% | 34.86% | 2,45,093 |
| Preferential Reservations | ||||
| Employee Shares Offered | 60,000 | 0.39% | NA | |
| Total Shares Offered | 1,54,65,861 | 100.00% | 100.00% | |
Investors can bid for a minimum of 22 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 22 | ₹14,564 |
| Retail (Max) | 13 | 286 | ₹1,89,332 |
| S-HNI (Min) | 14 | 308 | ₹2,03,896 |
| S-HNI (Max) | 68 | 1,496 | ₹9,90,352 |
| B-HNI (Min) | 69 | 1,518 | ₹10,04,916 |
Tarsons Products IPO raises ₹305.96 crore from anchor investors. Tarsons Products IPO Anchor bid date is November 12, 2021.
📝 Anchor Investors Letter (PDF)
| Bid Date | Fri, Nov 12, 2021 |
| Shares Offered | 46,21,757 |
| Anchor Portion (₹ Cr.) | 305.96 |
| Anchor lock-in period end date for 50% shares (30 Days) | Thu, Dec 23, 2021 |
| Anchor lock-in period end date for remaining shares (90 Days) | Mon, Feb 21, 2022 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Tarsons Products Limited is a leading Indian life sciences company with more than three decades of experience in the production and supply of labware products. The company manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems. The company's product portfolio is classified into three broad categories including consumables, reusables, and others. As of March 31, 2021, the company has a diversified product portfolio with over 1,700 SKUs across 300 products.
Trason's products are used in various laboratories across research organizations, academic institutes, pharmaceutical companies, Contract Research Organizations (CRO), diagnostic companies, and hospitals. The company has many reputed institutes, medical labs, and hospitals as its key clients.
Currently, the company has 5 manufacturing facilities located in West Bengal spread across approximately 20,000 sq. mts of area. The company has a strong distribution network across India comprising of over 141 authorized distributors as of March 31, 2021 and supplies its products to more than 40 countries.
Competitive Strengths:
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/prepayment of certain borrowings of our Company | 78.54 |
| 2 | Funding capital expenditure for the Proposed Expansion | 62.00 |
| 3 | General corporate purposes | 1.62 |
The Tarsons Products IPO is subscribed 77.49 times on November 17, 2021 5:00:00 PM (Day 3). The public issue subscribed 10.56 times in the retail category, 115.77 times in the QIB category, and 184.58 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 115.77 | 30,81,172 | 35,67,10,948 |
| NII | 184.58 | 23,10,880 | 42,65,47,616 |
| Retail | 10.56 | 53,92,052 | 5,69,13,164 |
| Employee | 1.83 | 60,000 | 1,09,956 |
| Total | 77.49 | 1,08,44,104 | 84,02,81,684 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead Managers’ fees | 24.15 |
| 2 | Commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 7.05 |
| 3 | Fees payable to the Registrar to the Offer & Banker to the Offer | 0.23 |
| 4 | Fees payable to the other advisors to the Offer | 0.03 |
| 5 | S D T & Co., Chartered Accountants, for providing the statement of special direct and indirect tax benefits available to our Company and to our Shareholders, and to verify the details and provided certifications with respect to certain information included in the DRHP | 0.16 |
| 6 | Statutory Auditors, for issuing the Restated Financial Information | 1.30 |
| 7 | Kalyan Bhattacharya, independent chartered engineer, in respect of the (i) installed capacity, production and capacity utilization of the manufacturing operations of our Company; and (ii) Proposed Expansion, for which the Company is in the process of raising capital by way of the proposed Offer | 0.00 |
| 8 | Frost & Sullivan for issuing the Frost & Sullivan Report prepared and released by Frost & Sullivan, commissioned and paid for by our Company in connection with the Offer | 0.30 |
| 9 | Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | 4.29 |
| 10 | Printing and distribution of issue stationery | 1.90 |
| 11 | Advertising and marketing expenses | 5.72 |
| 12 | Fee payable to legal counsels | 2.87 |
| 13 | Insurance in connection with the Offer | 0.15 |
| 14 | Miscellaneous | 2.55 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹662.00 | ₹662.00 |
| Open | ₹700.00 | ₹682.00 |
| Low | ₹634.00 | ₹680.00 |
| High | ₹840.00 | ₹818.40 |
| Last Trade | ₹840.00 | ₹818.40 |
Tarsons Products IPO is a main-board IPO of 1,54,65,861 equity shares of the face value of ₹2 aggregating up to ₹1,024 Crores. The issue is priced at ₹662 per share. The minimum order quantity is 22.
The IPO opens on Mon, Nov 15, 2021, and closes on Wed, Nov 17, 2021.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Tarsons Products IPO using UPI as a payment gateway. Zerodha customers can apply in Tarsons Products IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Tarsons Products IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Tarsons Products IPO opens on Mon, Nov 15, 2021 and closes on Wed, Nov 17, 2021.
Tarsons Products IPO lot size is 22, and the minimum amount required for application is ₹14,564.
You can apply in Tarsons Products IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Tarsons Products IPO will be done on Tuesday, November 23, 2021, and the allotted shares will be credited to your demat account by Thu, Nov 25, 2021. Check the Tarsons Products IPO allotment status.
The Tarsons Products IPO listing date is on Fri, Nov 26, 2021.
